Haemonetics | HAE - Current Liabilities


Haemonetics reported $300.84M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Baxter International USD 3.81B 218M Sep/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Boston Scientific USD 5.98B 446M Sep/2026
Cerus USD 100.8M 12.37M Dec/2025
Cooper Companies USD 1.87B 61.9M Jun/2026
Fresenius EUR 8.08B 986M Sep/2026
Fresenius Medical Care EUR 7.91B 727.93M Sep/2026
Globus Medical USD 507.94M 28.59M Sep/2026
Haemonetics USD 300.84M 37.6M Sep/2026
ICU Medical USD 514.63M 16.27M Sep/2026
Intuitive Surgical USD 3.23B 652.4M Sep/2026
Medtronic USD 11.8B 141M Jun/2026
Merit Medical Systems USD 265.08M 150K Sep/2026
Neogen USD 149.5M 8.7M Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Quidel USD 1.07B 73.7M Sep/2026
ResMed USD 1.32B 70.89M Sep/2026
STAAR Surgical USD 75.54M 2.15M Sep/2026
Steris USD 1.21B 75.5M Sep/2026
Stryker USD 6.5B 184M Sep/2026
Teleflex USD 917.1M 196.72M Sep/2026
Terumo JPY 306.08B 107.19B Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
US Physical Therapy USD 109.22M 691K Sep/2026
Zimmer Biomet Holdings USD 3.5B 488.9M Sep/2026